[EN] β-1,6-GLUCAN CETUXIMAB ANTIBODY CONJUGATES<br/>[FR] CONJUGUÉS DE Β-1,6-GLUCANE ET DE L'ANTICORPS CÉTUXIMAB
申请人:IMMUNEXCITE INC
公开号:WO2016196682A1
公开(公告)日:2016-12-08
The present invention encompasses embodiments in which cetuximab or a related cetuximab antibody is conjugated to β-1,6-glucan oligomers. Thus, the present invention includes, among other things, compositions including cetuximab conjugated to one or more β-1,6-glucan oligomers. The present invention further includes, among other things, methods of making and/or using such β-1,6-glucan conjugates. In certain embodiments, a β-1,6-glucan conjugate of the present invention is useful as a therapeutic or in a method of therapy.
本发明涵盖了将Cetuximab或相关的Cetuximab抗体与β-1,6-葡聚糖寡聚体结合的实施例。因此,本发明包括将Cetuximab与一个或多个β-1,6-葡聚糖寡聚体结合的组合物,以及制备和/或使用这样的β-1,6-葡聚糖结合物的方法等。在某些实施例中,本发明的β-1,6-葡聚糖结合物可用作治疗或治疗方法中的治疗剂。